EP337: A Patient-First Specialty Pharmacy, Not a Money-First Specialty Pharmacy, With Olivia Webb

In Episode 337, Stacey Richter talks with Olivia Webb, PharmD, author of the Acute Condition newsletter, about what it would take to build a "patient-first specialty pharmacy" — one dedicated not just to giving patients a decent experience but to actually improving outcomes, in a system where the patient is too often the product, not the customer.

WHAT YOU'LL LEARN

✅ Why the specialty pharmacy operational model isn't built to serve patients, but to fight over revenue and captive patient populations

✅ What makes a drug qualify as a "specialty" drug — and why there's no single definition

✅ What a patient-centric specialty pharmacy would actually look like

✅ Why infusion centers can become high-drama places, and who has a vested interest in patients taking specialty medications correctly

✅ Why the time may be ripe for disruption in specialty pharmacy, and what barriers stand in the way

WHY THIS MATTERS

The whole PBM/insurer/specialty pharmacy vertical stack rarely deals with patients directly — and when a patient asks a simple question about a six-figure therapy being injected into their arm, it's too often the case that no one has a good answer. There's a strong financial and clinical case for building specialty pharmacy around the patient instead of around the fight for revenue, but that would mean confronting the root cause of why it isn't built that way already.

MENTIONED IN THIS EPISODE

AEE15 with David Carmouche, MD, of Ochsner: Apple Podcasts | Spotify

=== LINKS ===

🔗 Show Notes with all mentioned links: Episode Page

🔗 Healthcare Industry Acronyms and Terms

✉️ Enjoy this podcast? Subscribe to the free weekly newsletter

🫙 Support the podcast with a small donation to the Tip Jar

📺 Subscribe to our YouTube channel

🎤 Listen on Apple Podcasts

🎤 Listen on Spotify

=== CONNECT WITH THE RHV TEAM ===

✭ LinkedIn ✭ Threads ✭ Bluesky ✭ X

00:00 Introduction.

04:11 Why did Olivia start thinking about a patient-centric specialty pharmacy?

05:33 "There's really no layer on top of it to make it look nice."

06:23 "You're kind of dealing with this vertical stack that doesn't really deal with patients frequently."

06:35 Is the specialty model more patient friendly or less?

07:08 What would a patient-centric specialty pharmacy look like?

07:58 "There's a lot of fragmentation; there's a lot of friction."

08:11 What's unique to specialty pharmacy prescriptions?

10:38 Why can infusion centers be a high-drama place?

12:15 What's "the question" around specialty pharmacy?

12:42 Who has the vested interest in ensuring patients take their medications correctly in specialty pharmacy?

14:39 "It's really just a unique area of healthcare where the people that I think of as the good guys and the bad guys completely flips."

16:05 Why might the time be ripe for disruption in the specialty pharmacy area?

19:56 "There's no one with a clear incentive to cap the prices."

20:09 What are the barriers in specialty pharmacy?

20:31 "The patient just isn't at the center, the financial incentive, in any direction."

29:22 "I think people who are designing these things need to see how patients are actually doing it."

29:50 "I think there's a lot of money here; I think this market is going to only increase in size."

30:10 "I think you need scale."

30:20 AEE15 with David Carmouche, MD, of Ochsner.